T1	CHEM 35 45	dobutamina
#1	AnnotatorNotes T1	C0012963; dobutamine; Organic Chemical · Pharmacologic Substance
T2	DISO 86 108	insuficiencia cardíaca
#2	AnnotatorNotes T2	C0018801; Heart failure; Disease or Syndrome
T3	CHEM 151 168	agente inotrópico
#3	AnnotatorNotes T3	C0304509; Inotropic agent (substance); Pharmacologic Substance
T4	ANAT 201 209	cardíaca
#4	AnnotatorNotes T4	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T5	ANAT 236 243	celular
#5	AnnotatorNotes T5	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T6	CHEM 247 253	calcio
#6	AnnotatorNotes T6	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T7	DISO 300 309	arritmias
#7	AnnotatorNotes T7	C0003811; Cardiac Arrhythmia; Disease or Syndrome
T8	DISO 341 363	insuficiencia cardíaca
#8	AnnotatorNotes T8	C0018801; Heart failure; Disease or Syndrome
T9	DISO 581 601	atraso de conducción
#9	AnnotatorNotes T9	C1398354; Conduction delay; Pathologic Function
T10	DISO 457 479	muerte súbita cardíaca
#10	AnnotatorNotes T10	C0085298; Sudden Cardiac Death; Pathologic Function
T11	ANAT 509 529	ventrículo izquierdo
#11	AnnotatorNotes T11	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T12	PROC 628 631	ECG
#12	AnnotatorNotes T12	C1623258; Electrocardiography; Diagnostic Procedure
T13	CHEM 742 752	dobutamina
#13	AnnotatorNotes T13	C0012963; dobutamine; Organic Chemical · Pharmacologic Substance
T14	PROC 1239 1243	FEVI
#14	AnnotatorNotes T14	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T15	PROC 905 917	randomizados
#15	AnnotatorNotes T15	C0034656; Randomization; Research Activity
T16	CHEM 949 962	levosimendana
#16	AnnotatorNotes T16	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T17	CHEM 972 982	dobutamina
#17	AnnotatorNotes T17	C0012963; dobutamine; Organic Chemical · Pharmacologic Substance
T18	CHEM 1111 1124	levosimendana
#18	AnnotatorNotes T18	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T19	CHEM 1127 1137	dobutamina
#19	AnnotatorNotes T19	C0012963; dobutamine; Organic Chemical · Pharmacologic Substance
T20	PROC 1192 1237	fracción de eyección del ventrículo izquierdo
#20	AnnotatorNotes T20	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T21	ANAT 1217 1237	ventrículo izquierdo
#21	AnnotatorNotes T21	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T22	CHEM 1331 1344	levosimendana
#22	AnnotatorNotes T22	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T23	PROC 1546 1550	FEVI
#23	AnnotatorNotes T23	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T24	CHEM 1479 1489	dobutamina
#24	AnnotatorNotes T24	C0012963; dobutamine; Organic Chemical · Pharmacologic Substance
T25	CHEM 1507 1519	medicamentos
#25	AnnotatorNotes T25	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T26	CHEM 1740 1750	dobutamina
#26	AnnotatorNotes T26	C0012963; dobutamine; Organic Chemical · Pharmacologic Substance
T27	CHEM 1714 1727	levosimendana
#27	AnnotatorNotes T27	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T28	PROC 1785 1788	ECG
#28	AnnotatorNotes T28	C1623258; Electrocardiography; Diagnostic Procedure
T29	ANAT 1884 1904	ventrículo izquierdo
#29	AnnotatorNotes T29	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T30	ANAT 1861 1879	fibras del músculo
T31	CHEM 1599 1612	levosimendana
#30	AnnotatorNotes T31	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T32	ANAT 100 108	cardíaca
#31	AnnotatorNotes T32	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T33	CHEM 291 297	calcio
#32	AnnotatorNotes T33	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T34	ANAT 355 363	cardíaca
#33	AnnotatorNotes T34	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T35	DISO 365 367	IC
#34	AnnotatorNotes T35	C0018801; Heart failure; Disease or Syndrome
T36	ANAT 471 479	cardíaca
#35	AnnotatorNotes T36	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T37	CHEM 726 739	levosimendana
#36	AnnotatorNotes T37	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T38	DISO 793 795	IC
#37	AnnotatorNotes T38	C0018801; Heart failure; Disease or Syndrome
T39	ANAT 810 817	sinusal
#38	AnnotatorNotes T39	C0037189; Sinoatrial Node; Body Part, Organ, or Organ Component
T40	DISO 859 871	IC isquémica
T41	PROC 937 945	infusión
#39	AnnotatorNotes T41	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T42	PROC 1696 1710	administración
#40	AnnotatorNotes T42	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T43	CHEM 19 32	levosimendana
#41	AnnotatorNotes T43	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T44	CHEM 125 138	levosimendana
#42	AnnotatorNotes T44	C0246904; levosimendan; Organic Chemical · Pharmacologic Substance
T45	LIVB 72 81	pacientes
#43	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T48	LIVB 327 336	pacientes
#44	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Spec_cue 434 443	riesgo de
T51	PHYS 549 560	contracción
#45	AnnotatorNotes T51	C0027045; Myocardial Contraction; Organ or Tissue Function
T53	LIVB 779 788	pacientes
#46	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 832 841	pacientes
#47	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T56	LIVB 1003 1010	hombres
#48	AnnotatorNotes T56	C0025266; Male population group; Population Group
T57	LIVB 1060 1069	pacientes
#49	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Duration 1397 1412	116,47±24,56 ms
T60	Neg_cue 1734 1736	no
T61	Spec_cue 1804 1816	posiblemente
T62	PHYS 1832 1843	contracción
#50	AnnotatorNotes T62	C0026820; Muscle Contraction; Physiologic Function
T64	PHYS 1204 1237	eyección del ventrículo izquierdo
#51	AnnotatorNotes T64	C2733342; Left ventricular ejection; Physiologic Function
T46	Neg_cue 267 269	no
T47	DISO 444 454	mortalidad
#52	AnnotatorNotes T47	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T55	Age 1036 1044	66,4±9,2
T65	Duration 1142 1154	120,44±23,82
T66	Duration 1159 1171	116,59±13,80
T59	PHYS 184 209	contractibilidad cardíaca
#53	AnnotatorNotes T59	C1258017; Heart Contractility; Organ or Tissue Function
T50	Spec_cue 530 536	pueden
A1	Assertion T7 Negated
A2	Assertion T10 Speculated
A3	Assertion T47 Speculated
A4	Assertion T26 Negated
A5	Assertion T62 Speculated
A6	Assertion T9 Speculated
R1	Negation Arg1:T46 Arg2:T7	
T52	Observation 277 297	sobrecarga de calcio
A7	Assertion T52 Negated
R2	Negation Arg1:T46 Arg2:T52	
R3	Causes Arg1:T33 Arg2:T52	
R4	Negation Arg1:T60 Arg2:T26	
R5	Used_for Arg1:T26 Arg2:T42	
R6	Used_for Arg1:T27 Arg2:T42	
T63	Neg_cue 1434 1436	no
T67	CONC 1442 1452	diferencia
A8	Assertion T67 Negated
#54	AnnotatorNotes T67	C1705241; Delta (difference); Quantitative Concept
R7	Negation Arg1:T63 Arg2:T67	
T68	Neg_cue 210 213	sin
T69	CONC 214 222	aumentar
A9	Assertion T69 Negated
#55	AnnotatorNotes T69	C0442805; Increase; Functional Concept
R8	Negation Arg1:T68 Arg2:T69	
T70	Spec_cue 1681 1688	sugiere
A10	Assertion T42 Speculated
A11	Assertion T27 Speculated
R9	Speculation Arg1:T70 Arg2:T42	
R10	Speculation Arg1:T70 Arg2:T27	
T71	Observation 1752 1778	acorta la duración del QRS
A12	Assertion T71 Speculated
R11	Speculation Arg1:T70 Arg2:T71	
A13	Assertion T51 Speculated
T72	Quantifier_or_Qualifier 561 570	asíncrona
A14	Assertion T72 Speculated
R12	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T72	
R13	Speculation Arg1:T50 Arg2:T51	
R14	Speculation Arg1:T50 Arg2:T72	
R15	Speculation Arg1:T61 Arg2:T62	
T73	Quantifier_or_Qualifier 1844 1853	colectiva
A15	Assertion T73 Speculated
R16	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T73	
R17	Causes Arg1:T62 Arg2:T71	
T74	Observation 1 8	Efectos
#56	AnnotatorNotes T74	C1518681; Outcome of Therapy; Finding (?)
R18	Causes Arg1:T43 Arg2:T74	
T75	Quantifier_or_Qualifier 9 15	agudos
#57	AnnotatorNotes T75	C0439557; Acute phase; Temporal Concept
R19	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T75	
T76	CONC 52 68	duración del QRS
#58	AnnotatorNotes T76	C1880451; Mean QRS Duration; Quantitative Concept (?)
R20	Location_of Arg1:T32 Arg2:T2	
R21	Experiences Arg1:T45 Arg2:T2	
R22	Experiences Arg1:T45 Arg2:T74	
R25	Location_of Arg1:T4 Arg2:T59	
T78	PHYS 226 243	captación celular
R28	Location_of Arg1:T5 Arg2:T78	
R29	Used_for Arg1:T6 Arg2:T78	
#60	AnnotatorNotes T78	C3888108; Import into cell; Cell Function
R30	Before Arg1:T44 Arg2:T52	
R31	Before Arg1:T3 Arg2:T7	
R32	Location_of Arg1:T34 Arg2:T8	
R33	Location_of Arg1:T34 Arg2:T35	
R34	Experiences Arg1:T48 Arg2:T8	
R35	Experiences Arg1:T48 Arg2:T35	
T79	Observation 373 400	duración prolongada del QRS
#61	AnnotatorNotes T79	C0235475; Wide QRS complex; Finding
R36	Experiences Arg1:T48 Arg2:T79	
R37	Before Arg1:T79 Arg2:T47	
R38	Before Arg1:T79 Arg2:T10	
R39	Speculation Arg1:T49 Arg2:T47	
R40	Speculation Arg1:T49 Arg2:T10	
R41	Experiences Arg1:T48 Arg2:T10	
R42	Location_of Arg1:T36 Arg2:T10	
R43	Experiences Arg1:T48 Arg2:T47	
T80	Observation 607 621	QRS prolongado
#62	AnnotatorNotes T80	C0235475; Wide QRS complex; Finding
T81	Observation 481 529	Cambios estructurales en el ventrículo izquierdo
R44	Location_of Arg1:T11 Arg2:T81	
R45	Before Arg1:T81 Arg2:T51	
R46	Causes Arg1:T51 Arg2:T9	
R48	Causes Arg1:T51 Arg2:T80	
T82	Observation 708 715	efectos
#63	AnnotatorNotes T82	C1518681; Outcome of Therapy; Finding (?)
T83	Quantifier_or_Qualifier 716 722	agudos
#64	AnnotatorNotes T83	C0439557; Acute phase; Temporal Concept
R49	Causes Arg1:T37 Arg2:T82	
R50	Causes Arg1:T13 Arg2:T82	
R51	Has_Quantifier_or_Qualifier Arg1:T82 Arg2:T83	
T84	CONC 759 775	duración del QRS
#65	AnnotatorNotes T84	C1880451; Mean QRS Duration; Quantitative Concept (?)
R52	Experiences Arg1:T53 Arg2:T38	
R53	Experiences Arg1:T53 Arg2:T82	
R54	Experiences Arg1:T53 Arg2:T37	
R55	Experiences Arg1:T53 Arg2:T13	
T85	Quantifier_or_Qualifier 796 801	grave
#66	AnnotatorNotes T85	C1547227; Severe - Severity of Illness Code; Intellectual Product
R56	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T85	
T86	Observation 804 817	ritmo sinusal
#67	AnnotatorNotes T86	C0232201; Sinus rhythm; Finding
R57	Experiences Arg1:T53 Arg2:T86	
R58	Location_of Arg1:T39 Arg2:T86	
#68	AnnotatorNotes T40	C5577977; Ischaemic heart failure; Disease or Syndrome
R59	Experiences Arg1:T54 Arg2:T40	
T87	Quantifier_or_Qualifier 842 854	consecutivos
#69	AnnotatorNotes T87	C1707491; Consecutive; Qualitative Concept
R60	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T87	
R61	Before Arg1:T15 Arg2:T41	
R62	Used_for Arg1:T16 Arg2:T41	
R63	Used_for Arg1:T17 Arg2:T41	
R64	Experiences Arg1:T54 Arg2:T41	
R65	Experiences Arg1:T45 Arg2:T43	
R66	Experiences Arg1:T45 Arg2:T1	
R67	Experiences Arg1:T56 Arg2:T40	
R68	Experiences Arg1:T56 Arg2:T41	
R69	Has_Age Arg1:T57 Arg2:T55	
R70	Has_Age Arg1:T56 Arg2:T55	
R71	Has_Age Arg1:T54 Arg2:T55	
R72	Experiences Arg1:T57 Arg2:T41	
R73	Experiences Arg1:T57 Arg2:T40	
T88	CONC 1074 1082;1089 1096	duración del QRS
#70	AnnotatorNotes T88	C1880451; Mean QRS Duration; Quantitative Concept (?)
T89	Quantifier_or_Qualifier 1083 1088	basal
#71	AnnotatorNotes T89	C1442488; Baseline; Quantitative Concept
R74	Has_Quantifier_or_Qualifier Arg1:T88 Arg2:T89	
R75	Has_Duration_or_Interval Arg1:T88 Arg2:T65	
R76	Has_Duration_or_Interval Arg1:T88 Arg2:T66	
R77	Location_of Arg1:T21 Arg2:T64	
R78	Location_of Arg1:T21 Arg2:T20	
R79	Location_of Arg1:T21 Arg2:T14	
T90	Observation 1192 1237;1252 1262	fracción de eyección del ventrículo izquierdo disminuida
#72	AnnotatorNotes T90	C1096403; Left ventricular ejection fraction decreased; Finding
T91	Observation 1239 1243;1252 1262	FEVI disminuida
#73	AnnotatorNotes T91	C1096403; Left ventricular ejection fraction decreased; Finding
T92	CONC 1349 1365	duración del QRS
#74	AnnotatorNotes T92	C1880451; Mean QRS Duration; Quantitative Concept (?)
R85	Has_Duration_or_Interval Arg1:T92 Arg2:T58	
T93	CONC 1380 1391	valor basal
#75	AnnotatorNotes T93	C1442488; Baseline; Quantitative Concept
T95	Observation 1532 1550	aumento en la FEVI
R88	Causes Arg1:T25 Arg2:T95	
R90	Causes Arg1:T31 Arg2:T95	
T96	Quantifier_or_Qualifier 1789 1802	de superficie
R91	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T96	
T97	Quantifier_or_Qualifier 632 645	de superficie
R93	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T97	
R94	Location_of Arg1:T30 Arg2:T62	
R95	Location_of Arg1:T29 Arg2:T62	
R96	Before Arg1:T42 Arg2:T71	
T98	Quantifier_or_Qualifier 1453 1466	significativa
A16	Assertion T98 Negated
#77	AnnotatorNotes T98	C0750502; Significant; Idea or Concept
R98	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T98	
R99	Negation Arg1:T63 Arg2:T98	
#59	AnnotatorNotes T95	C4478905; Increased ejection fraction of left ventricle; Finding
R23	Causes Arg1:T1 Arg2:T74	
#76	AnnotatorNotes T72	C0439581; Asynchronous pattern; Temporal Concept
#78	AnnotatorNotes T96	C0205148; Surface; Spatial Concept
#79	AnnotatorNotes T97	C0205148; Surface; Spatial Concept
#80	AnnotatorNotes T30	C0242697; Muscle Fibers; Cell
A17	Experiencer T45 Patient
A18	Experiencer T48 Patient
A19	Experiencer T53 Patient
A20	Experiencer T54 Patient
A21	Experiencer T56 Patient
A22	Experiencer T57 Patient
R24	Has_Result_or_Value Arg1:T14 Arg2:T91	
R26	Has_Result_or_Value Arg1:T20 Arg2:T90	
R27	Has_Result_or_Value Arg1:T23 Arg2:T95	
